Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DDX60 |
| Upstream (Parents) |
|---|
| (<<) OAS2 → DDX60 |
| (<<) GBP1 → DDX60 |
| (<<) OASL → DDX60 |
| (<<) IFI44L → DDX60 |
| (<<) IFI44 → DDX60 |
| Downstream (Children) |
|---|
| DDX60 → DDX58 (>>) |
| DDX60 → OASL (>>) |
| DDX60 → PSMB9 (>>) |
| DDX60 → SAMD9 (>>) |
| DDX60 → SLC16A4 (>>) |
| DDX60 → IFI44L (>>) |
| DDX60 → ZC3H15 (>>) |
| DDX60 → IL3 (>>) |
| DDX60 → MAGEA9B///MAGEA9 (>>) |
| DDX60 → HMGN5 (>>) |
| DDX60 → OAS1 (>>) |
| DDX60 → BIRC3 (>>) |
